Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· AI x biologyAudio language not provided

SB000: a first single-gene rejuvenation factor safer than Yamanaka factors

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

This video summarises the paper “A single factor for safer cellular rejuvenation” by Lucas Paulo de Lima Camillo et al. (bioRxiv, 2025). The authors report the discovery of SB000, the first single gene capable of rejuvenating human cells as effectively as the Yamanaka factors (OSKM), without triggering pluripotency or loss of cell identity. Using a powerful single-cell transcriptomic ageing clock (AC3), they screened genes directly for age reversal instead of stemness. SB000 rejuvenated fibroblasts and keratinocytes across germ layers, reversing both transcriptomic and epigenetic age by up to 13 years, lowering senescence markers, and restoring youthful collagen secretion, whilst maintaining somatic identity. This work demonstrates that cellular rejuvenation can be decoupled from reprogramming, paving the way for safer, single-factor anti-ageing therapies.

AI x biology · 11 min · Source published: 2025-10-29

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…